Skip to content
Sample Page
Author:
AxoSim Inc.
Posted Date:
May 26, 2026
28bio Launches CNS-3D Alzheimer’s Model to Predict Therapeutic Efficacy
AxoSim Inc.
May 26, 2026
28bio Launches CNS-3D Inflammatory Organoids to Predict Anti-inflammatory Therapeutic Efficacy
AxoSim Inc.
May 19, 2026
28bio Launches CNS-3D Myelinated Organoids to Predict Therapeutic Efficacy
AxoSim Inc.
May 12, 2026
28bio’s Endurance Study Meets Primary Endpoint, Showing CNS-3D Brain Organoids Predict Clinical Seizure Liability
AxoSim Inc.
March 23, 2026
